CovidChloroV1, Main, Exploration, bibRecord, 001741

COVID-19 pneumonia in kidney transplant recipients-Where we are?

Identifieur interne : 001741 ( Main/Exploration ); précédent : 001740; suivant : 001742

COVID-19 pneumonia in kidney transplant recipients-Where we are?

Auteurs : David José De Barros Machado [Brésil] ; Luiz Estevam Ianhez [Brésil]

Source :

Transplant infectious disease : an official journal of the Transplantation Society [ 1399-3062 ] ; 2020.

RBID : pubmed:32364677

Descripteurs français

KwdFr :
- ARN viral (isolement et purification), Antiviraux (usage thérapeutique), Brésil (MeSH), Défaillance rénale chronique (chirurgie), Défaillance rénale chronique (immunologie), Humains (MeSH), Immunosuppresseurs (effets indésirables), Mâle (MeSH), Poumon (imagerie diagnostique), Receveurs de transplantation (MeSH), Rejet du greffon (immunologie), Rejet du greffon (prévention et contrôle), Résultat thérapeutique (MeSH), Sujet immunodéprimé (MeSH), Sujet âgé (MeSH), Tomodensitométrie (MeSH), Transplantation rénale (effets indésirables).
MESH :
- chirurgie : Défaillance rénale chronique.
- effets indésirables : Immunosuppresseurs, Transplantation rénale.
- imagerie diagnostique : Poumon.
- immunologie : Défaillance rénale chronique, Rejet du greffon.
- isolement et purification : ARN viral.
- prévention et contrôle : Rejet du greffon.
- usage thérapeutique : Antiviraux.
- Brésil, Humains, Mâle, Receveurs de transplantation, Résultat thérapeutique, Sujet immunodéprimé, Sujet âgé, Tomodensitométrie.
Wicri :
- geographic : Brésil.

English descriptors

KwdEn :
- Aged (MeSH), Antiviral Agents (therapeutic use), Brazil (MeSH), COVID-19 (diagnosis), COVID-19 (drug therapy), COVID-19 (immunology), COVID-19 (virology), COVID-19 Nucleic Acid Testing (MeSH), Graft Rejection (immunology), Graft Rejection (prevention & control), Humans (MeSH), Immunocompromised Host (MeSH), Immunosuppressive Agents (adverse effects), Kidney Failure, Chronic (immunology), Kidney Failure, Chronic (surgery), Kidney Transplantation (adverse effects), Lung (diagnostic imaging), Male (MeSH), RNA, Viral (isolation & purification), SARS-CoV-2 (genetics), SARS-CoV-2 (immunology), SARS-CoV-2 (isolation & purification), Tomography, X-Ray Computed (MeSH), Transplant Recipients (MeSH), Treatment Outcome (MeSH).
MESH :
- chemical , adverse effects : Immunosuppressive Agents.
- chemical , isolation & purification : RNA, Viral.
- chemical , therapeutic use : Antiviral Agents.
- geographic : Brazil.
- adverse effects : Kidney Transplantation.
- diagnosis : COVID-19.
- diagnostic imaging : Lung.
- drug therapy : COVID-19.
- genetics : SARS-CoV-2.
- immunology : COVID-19, Graft Rejection, Kidney Failure, Chronic, SARS-CoV-2.
- isolation & purification : SARS-CoV-2.
- prevention & control : Graft Rejection.
- surgery : Kidney Failure, Chronic.
- virology : COVID-19.
- Aged, COVID-19 Nucleic Acid Testing, Humans, Immunocompromised Host, Male, Tomography, X-Ray Computed, Transplant Recipients, Treatment Outcome.

Abstract

In late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first coronavirus disease 2019 (COVID-19) in Brazil was diagnosed, and by now, we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases.

DOI: 10.1111/tid.13306
PubMed: 32364677
PubMed Central: PMC7261981

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001795
to stream Main, to step Curation: 001795

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 pneumonia in kidney transplant recipients-Where we are?</title>
<author><name sortKey="Machado, David Jose De Barros" sort="Machado, David Jose De Barros" uniqKey="Machado D" first="David José De Barros" last="Machado">David José De Barros Machado</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital Alemão Oswaldo Cruz, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
<orgName type="university">Université de São Paulo</orgName>
</affiliation>
</author>
<author><name sortKey="Ianhez, Luiz Estevam" sort="Ianhez, Luiz Estevam" uniqKey="Ianhez L" first="Luiz Estevam" last="Ianhez">Luiz Estevam Ianhez</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital Alemão Oswaldo Cruz, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32364677</idno>
<idno type="pmid">32364677</idno>
<idno type="doi">10.1111/tid.13306</idno>
<idno type="pmc">PMC7261981</idno>
<idno type="wicri:Area/Main/Corpus">001795</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001795</idno>
<idno type="wicri:Area/Main/Curation">001795</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001795</idno>
<idno type="wicri:Area/Main/Exploration">001795</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 pneumonia in kidney transplant recipients-Where we are?</title>
<author><name sortKey="Machado, David Jose De Barros" sort="Machado, David Jose De Barros" uniqKey="Machado D" first="David José De Barros" last="Machado">David José De Barros Machado</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital Alemão Oswaldo Cruz, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
<orgName type="university">Université de São Paulo</orgName>
</affiliation>
</author>
<author><name sortKey="Ianhez, Luiz Estevam" sort="Ianhez, Luiz Estevam" uniqKey="Ianhez L" first="Luiz Estevam" last="Ianhez">Luiz Estevam Ianhez</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Hospital Alemão Oswaldo Cruz, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Transplant infectious disease : an official journal of the Transplantation Society</title>
<idno type="eISSN">1399-3062</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Brazil (MeSH)</term>
<term>COVID-19 (diagnosis)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (immunology)</term>
<term>COVID-19 (virology)</term>
<term>COVID-19 Nucleic Acid Testing (MeSH)</term>
<term>Graft Rejection (immunology)</term>
<term>Graft Rejection (prevention & control)</term>
<term>Humans (MeSH)</term>
<term>Immunocompromised Host (MeSH)</term>
<term>Immunosuppressive Agents (adverse effects)</term>
<term>Kidney Failure, Chronic (immunology)</term>
<term>Kidney Failure, Chronic (surgery)</term>
<term>Kidney Transplantation (adverse effects)</term>
<term>Lung (diagnostic imaging)</term>
<term>Male (MeSH)</term>
<term>RNA, Viral (isolation & purification)</term>
<term>SARS-CoV-2 (genetics)</term>
<term>SARS-CoV-2 (immunology)</term>
<term>SARS-CoV-2 (isolation & purification)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
<term>Transplant Recipients (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (isolement et purification)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Brésil (MeSH)</term>
<term>Défaillance rénale chronique (chirurgie)</term>
<term>Défaillance rénale chronique (immunologie)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (effets indésirables)</term>
<term>Mâle (MeSH)</term>
<term>Poumon (imagerie diagnostique)</term>
<term>Receveurs de transplantation (MeSH)</term>
<term>Rejet du greffon (immunologie)</term>
<term>Rejet du greffon (prévention et contrôle)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sujet immunodéprimé (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Tomodensitométrie (MeSH)</term>
<term>Transplantation rénale (effets indésirables)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Brazil</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Kidney Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="chirurgie" xml:lang="fr"><term>Défaillance rénale chronique</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Immunosuppresseurs</term>
<term>Transplantation rénale</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Défaillance rénale chronique</term>
<term>Rejet du greffon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>COVID-19</term>
<term>Graft Rejection</term>
<term>Kidney Failure, Chronic</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>ARN viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Graft Rejection</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Rejet du greffon</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Kidney Failure, Chronic</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>COVID-19 Nucleic Acid Testing</term>
<term>Humans</term>
<term>Immunocompromised Host</term>
<term>Male</term>
<term>Tomography, X-Ray Computed</term>
<term>Transplant Recipients</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Brésil</term>
<term>Humains</term>
<term>Mâle</term>
<term>Receveurs de transplantation</term>
<term>Résultat thérapeutique</term>
<term>Sujet immunodéprimé</term>
<term>Sujet âgé</term>
<term>Tomodensitométrie</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Brésil</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first coronavirus disease 2019 (COVID-19) in Brazil was diagnosed, and by now, we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32364677</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>02</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3062</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>22</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Transplant infectious disease : an official journal of the Transplantation Society</Title>
<ISOAbbreviation>Transpl Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>COVID-19 pneumonia in kidney transplant recipients-Where we are?</ArticleTitle>
<Pagination><MedlinePgn>e13306</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/tid.13306</ELocationID>
<Abstract><AbstractText>In late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first coronavirus disease 2019 (COVID-19) in Brazil was diagnosed, and by now, we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases.</AbstractText>
<CopyrightInformation>© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Machado</LastName>
<ForeName>David José de Barros</ForeName>
<Initials>DJB</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-3874-7957</Identifier>
<AffiliationInfo><Affiliation>Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ianhez</LastName>
<ForeName>Luiz Estevam</ForeName>
<Initials>LE</Initials>
<AffiliationInfo><Affiliation>Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Denmark</Country>
<MedlineTA>Transpl Infect Dis</MedlineTA>
<NlmUniqueID>100883688</NlmUniqueID>
<ISSNLinking>1398-2273</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Transpl Int. 2020 Dec;33(12):1837-1842</RefSource>
<PMID Version="1">32935356</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006084" MajorTopicYN="N">Graft Rejection</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016030" MajorTopicYN="N">Kidney Transplantation</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">heparin</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine and azithromycin</Keyword>
<Keyword MajorTopicYN="N">infectious diseases</Keyword>
<Keyword MajorTopicYN="N">kidney and liver transplantation</Keyword>
<Keyword MajorTopicYN="N">nonpathogen-specifc immune parameters</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32364677</ArticleId>
<ArticleId IdType="doi">10.1111/tid.13306</ArticleId>
<ArticleId IdType="pmc">PMC7261981</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2020 Jul;20(7):1849-1858</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32301155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2020 Jul;20(7):1941-1943</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32233067</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Public Health. 2016 May-Jun;9(3):227-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27095301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clinics (Sao Paulo). 2019;74:e832</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31116230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2020 Jul;20(7):1944-1946</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Coll Cardiol. 2017 Nov 7;70(19):2411-2420</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29096812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2012 Apr;165(1):112-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22349148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2020 Jul;20(7):1859-1863</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32181990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21221847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Kidney Int. 2020 Jun;97(6):1083-1088</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32354634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Urol. 2020 Jun;77(6):742-747</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32249089</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transpl Infect Dis. 2020 Oct;22(5):e13306</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32364677</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2020 Jul;20(7):1922-1924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282991</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2020 Jul;20(7):1875-1878</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32198834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32220112</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Brésil</li>
</country>
<region><li>État de São Paulo</li>
</region>
<settlement><li>São Paulo</li>
</settlement>
<orgName><li>Université de São Paulo</li>
</orgName>
</list>
<tree><country name="Brésil"><region name="État de São Paulo"><name sortKey="Machado, David Jose De Barros" sort="Machado, David Jose De Barros" uniqKey="Machado D" first="David José De Barros" last="Machado">David José De Barros Machado</name>
</region>
<name sortKey="Ianhez, Luiz Estevam" sort="Ianhez, Luiz Estevam" uniqKey="Ianhez L" first="Luiz Estevam" last="Ianhez">Luiz Estevam Ianhez</name>
<name sortKey="Machado, David Jose De Barros" sort="Machado, David Jose De Barros" uniqKey="Machado D" first="David José De Barros" last="Machado">David José De Barros Machado</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001741 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001741 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32364677
   |texte=   COVID-19 pneumonia in kidney transplant recipients-Where we are?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32364677" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

COVID-19 pneumonia in kidney transplant recipients-Where we are?

COVID-19 pneumonia in kidney transplant recipients-Where we are?

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki